Common use of Funding of Development Program Clause in Contracts

Funding of Development Program. P&U shall be responsible for conducting, and for all expenses related to, preclinical development and clinical trials for all Products containing Candidate Drugs, including, without limitation, toxicology studies, pharmacology studies, formulation, clinical trials, and regulatory filings. If Geron co-promotes a particular Product in the U.S. pursuant to Article 11 below, P&U shall be entitled to the Clinical Expense Credit * Certain portions of this Exhibit have been omitted for which confidential treatment has been requested and filed separately with the Securities and Exchange Commission. against royalties due Geron for that Product; provided however, that in no event shall any Clinical Expense Credit or any portion thereof be applied more than once.